@misc{indiciae968f5ec48c56,
  title = {IL-6R blockade with tocilizumab disrupts pericyte-and tumor cell-driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer},
  author = {Przanowska, R. K. and Gomez-Villa, J. and Liu, V. J. and Antonides-Jensen, N. and Visvabharathy, L. and Alverdy, J. C. and Hernandez, S. L. and Yee, S. S.},
  year = {2026},
  doi = {10.64898/2026.01.29.702661},
  url = {https://www.biorxiv.org/content/10.64898/2026.01.29.702661v1},
  note = {Source identifier: 10.64898/2026.01.29.702661}
}